Expert Opinion on Pharmacotherapy

Expert Opin Pharmacother

1465-6566

1744-7666

Therapeutic Area

Pharmacology, Rare Diseases

Clinical Pharmacists, Clinical Pharmacologists, Clinicians, Hospitalists, Industrial Scientists, Medical Directors, Pharmaceutical Benefits Managers, Pharmacists, Pharmaco-Epidemiologists, Pharmacologists, Policy Makers, Researchers, Scientists

Expert Opinion on Pharmacotherapy [ISSN 1465-6566]; [e-ISSN 1744-7666] is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Expert Opinion on Pharmacotherapy addresses the needs of research and development, regulatory and marketing decision makers in the pharmaceutical industry and decision makers in healthcare provision. The Editors welcome: Reviews covering new drugs/drug classes for specific diseases, from development Phase III to those that have been available to pharmacopoeia for up to 5 years, and their potential impact on future treatment strategies. Drug Evaluations reviewing the clinical and pharmacological data on a particular drug. Original Research papers reporting the results of clinical investigations on agents that are in Phase III and IV clinical trials and pharmacologically based studies with a strong link to clinical practice.

No associations affiliated with this journal

Taylor & Francis, Inc. - UK

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines